Fig 3A
|
Mouse anti-human CD133 (Miltenyi Biotec) |
Goat anti-mouse IgG-Cy5 |
Rabbit anti-human E-cadherin (Santa Cruz) |
Goat anti-rabbit IgG-FITC |
Fig 3B
|
Rabbit anti-human CD133 (Abcam) |
Goat anti-rabbit IgG-FITC |
Mouse anti-human vimentin (Santa Cruz) |
Goat anti-mouse IgG-Cy5 |
Fig 3C
|
PE-conjugated mouse anti-human CD133 (Miltenyi Biotec) |
- |
Rabbit anti-human E-cadherin (Santa Cruz) |
Goat anti-rabbit IgG-FITC |
Mouse anti-human vimentin (Santa Cruz) |
Goat anti-mouse IgG-Cy5 |
Fig 4A
|
PE-conjugated mouse anti-human CD133 (Miltenyi Biotec) |
- |
Mouse anti-human B7H1 (provided by Prof. Lieping Chen, Yale University, USA) |
Goat anti-mouse IgG-FITC |
Fig 4B (C)S1 Fig
|
Rabbit anti-human CD133 (Abcam) |
Goat anti-rabbit IgG-Cy3 |
Mouse anti-human B7H1 (as in Fig 4A) |
Goat anti-mouse IgG-FITC |
APC-conjugated mouse anti-human EpCAM (Miltenyi Biotec) |
- |
Fig 5A
|
Mouse anti-human B7H1 (as in Fig 4A) |
Goat anti-mouse IgG-Cy5 |
Rabbit anti-human E-cadherin (Santa Cruz) |
Goat anti-rabbit IgG-FITC |
Fig 5B
|
Rabbit anti-human B7H1 (Santa Cruz) |
Goat anti-rabbit IgG-FITC |
Mouse anti-human vimentin (Santa Cruz) |
Goat anti-mouse IgG-Cy5 |